Hsbc Holdings PLC Ligand Pharmaceuticals Inc Put Options Transaction History

Hsbc Holdings PLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $1.61 Million - $1.94 Million	-15,000 Reduced 16.67%	75,000 $8.56 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $9.48 Million - $12.8 Million	89,500 Added 17900.0%	90,000 $11.3 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $64,180 - $136,065	500 New	500 $68,000

267

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.9B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.